サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1588364

バイオチップの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年

Biochip Market Size, Share & Trends Analysis Report By Type (DNA Chips, Protein Chips, Lab-on-chip, Tissue Arrays, Cell Arrays), By End Use, By Region, And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 120 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
バイオチップの市場規模、シェア、動向分析レポート：タイプ別、最終用途別、地域別、セグメント予測、2025年～2030年
出版日: 2024年10月24日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

バイオチップ市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のバイオチップの市場規模は2030年までに263億米ドルに達し、2025年から2030年までのCAGRは11.41%で拡大すると推定されています。

創薬や薬剤開発に対する要求の高まりと個別化医療の採用が相まって、業界の成長を後押しする可能性が高いです。さらに、世界中のバイオテクノロジー企業による次世代シーケンシングの導入の増加が製品需要を押し上げています。例えば、2021年12月、アボット社は外傷性脳損傷（TBI）血液用のポータブル分析装置であるi-STAT TBI Plasma testのCEマークを取得しました。このため、同社は欧州連合（EU）での事業拡大を認められています。シーケンシング技術の革新により、研究者はDNA分子を完全なヒトゲノムのレベルまで解読できるようになった。

サーモフィッシャーサイエンティフィックのIon Torrentチップは、合成技術によるシーケンスに基づく技術のひとつです。このチップは次世代シーケンシング（NGS）技術の進歩であり、超並列シーケンシングをあらゆる研究室にとって費用対効果の高いものにします。したがって、NGSアプリケーションを強化するバイオチップの開発は、業界の成長をサポートすると予想されます。同様に、バイオチップの国内生産を促進する政府ベースのイニシアチブの増加は、今後数年間の成長をサポートすると思われます。この戦略的イニシアチブは、製品の現地需要と供給を一致させるためのものです。例えば、2022年7月、SiPhox, Inc.はベイカー・ポリト政権から681,631米ドル相当の助成金を受け取った。

この資金援助は、プラガブル・フォトニック・バイオチップの大量生産のための製造施設の開発を加速させるためのものです。創薬、ワクチン開発、分散型診断などのバイオテクノロジー分野からの需要増に対応するため、月産100個程度だったバイオチップの生産量を月産5,000個程度まで加速させると推定されています。このような投資は、今後数年間の業界の成長を補うものと思われます。COVID-19パンデミックは予測期間中、業界の成長にプラスの影響を与えると予測されます。様々な企業がパンデミックに対処するための革新的なソリューションを開発するために協力しました。例えば、2020年3月、SkyWater TechnologyはMGIとの協業を発表し、マイクロ流体MEMSデバイスを含むCOVID-19シーケンスに不可欠なコンポーネントを供給します。

個別化医療への要求の高まりは、今後数年間、この業界にとって重要な応用分野になる可能性が高いです。バイオチップは分子診断における重要なコンポーネントとして台頭しているため、ポイントオブケア診断におけるバイオチップの使用は個別化医療の開発をスムーズにすると予想されます。また、マイクロアレイを用いた遺伝子発現プロファイリングにより、分子分類に基づくがんの個別化治療の進展が期待されます。しかし、バイオチップの製造にかかるコストはかなり高く、エンドユーザーにとっては高価格になります。例えば、Josep Carreras Leukaemia Research Institute（IJC）は研究者にマイクロアレイを提供しています。GeneChip Human Gene 2.0 STの全トランスクリプト発現解析とプロファイリングにかかるコストは、新鮮サンプルで456～593米ドルです。

バイオチップ市場レポートハイライト

  • DNAチップタイプは、がんの迅速かつ正確な検出に対する高い需要により、2024年に最大の収益シェアを占めました。
  • ラボオンチップの創薬アプリケーションセグメントは、バイオチップが創薬＆開発全体のコスト低減に役立つことから、予測期間中により速い速度で成長すると予測されています。
  • バイオテクノロジーおよび製薬企業エンドユーザーセグメントは、創薬＆開発の増加とともに個別化医薬品の必要性から、2024年に大きな収益シェアを獲得しました。
  • 北米は、高い研究開発投資とベンチャーキャピタルによる新興企業への資本アクセスとバイオチップのアプリケーション開発により、2024年に最大の収益シェアを占めました。
  • アジア太平洋地域は、2025年から2030年にかけて最も速いCAGRを記録すると予測されています。これは、国内製品製造を促進するための地方自治体の様々な取り組みによるものです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/補助市場見通し
  • 市場力学
    • 市場 促進要因分析
    • 市場抑制要因分析
  • 業界分析ツール
    • ポーターのファイブフォース分析
    • PESTEL分析
    • COVID-19の影響分析

第4章 タイプ別グループビジネス分析

  • タイプセグメントダッシュボード
  • バイオチップ市場タイプ変動分析
  • バイオチップ市場規模と動向分析、タイプ別、2018～2030年
  • DNAチップ
    • DNAチップ市場推計・予測、2018年-2030年
    • がんの診断と治療
    • 遺伝子発現
    • SNPジェノタイピング
    • ゲノミクス
    • 創薬
    • 農業バイオテクノロジー
    • その他
  • プロテインチップ
    • プロテインチップ市場推計・予測、2018年-2030年
    • プロテオミクス
    • 発現プロファイリング
    • 診断
    • HTS
    • 創薬
    • その他
  • ラボオンチップ
    • ラボオンチップ市場推計・予測、2018年-2030年
    • ゲノミクス
    • IVDとPOC
    • プロテオミクス
    • 創薬
    • その他
  • 組織アレイ
    • 組織アレイ市場推計・予測、2018年-2030年
  • セルアレイ
    • セルアレイ市場推計・予測、2018年-2030年

第5章 最終用途別ビジネス分析

  • 最終用途セグメントダッシュボード
  • バイオチップ市場の最終用途変動分析
  • バイオチップ市場規模と動向分析、最終用途別、2018～2030年
  • バイオテクノロジーおよび製薬会社
  • 病院と診断センター
  • 学術研究機関
  • その他

第6章 地域別ビジネス分析（タイプ別、最終用途別）

  • 地域ダッシュボード
  • 市場規模と予測および動向分析、2024年と2030年
  • 北米
    • 北米バイオチップ市場、2018年-2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 欧州のバイオチップ市場、2018年-2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • アジア太平洋バイオチップ市場、2018年-2030年
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ラテンアメリカのバイオチップ市場、2018年-2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 中東・アフリカバイオチップ市場、2018年～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 企業分類
  • 戦略マッピング
  • 企業市況分析、2024年
  • 企業プロファイル
    • Agilent Technologies
    • PerkinElmer, Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Standard BioTools Inc.
    • GE HealthCare
    • IBIOCHIPS
    • LI-COR, Inc.
    • Cellix Ltd
    • Randox Laboratories Ltd.
図表

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global biochip market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global biochip market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America biochip market, by country, 2018 - 2030 (USD Million)
  • Table 6 North America biochip market, by type, 2018 - 2030 (USD Million)
  • Table 7 North America biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 8 U.S. biochip market, by type, 2018 - 2030 (USD Million)
  • Table 9 U.S. biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Canada biochip market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Mexico biochip market, by type, 2018 - 2030 (USD Million)
  • Table 13 Mexico biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 14 Europe biochip market, by country, 2018 - 2030 (USD Million)
  • Table 15 Europe biochip market, by type, 2018 - 2030 (USD Million)
  • Table 16 Europe biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany biochip market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK biochip market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 21 France biochip market, by type, 2018 - 2030 (USD Million)
  • Table 22 France biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Italy biochip market, by type, 2018 - 2030 (USD Million)
  • Table 24 Italy biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Spain biochip market, by type, 2018 - 2030 (USD Million)
  • Table 26 Spain biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Denmark biochip market, by type, 2018 - 2030 (USD Million)
  • Table 28 Denmark biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Sweden biochip market, by type, 2018 - 2030 (USD Million)
  • Table 30 Sweden biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Norway biochip market, by type, 2018 - 2030 (USD Million)
  • Table 32 Norway biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific biochip market, by country, 2018 - 2030 (USD Million)
  • Table 34 Asia Pacific biochip market, by type, 2018 - 2030 (USD Million)
  • Table 35 Asia Pacific biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 36 China biochip market, by type, 2018 - 2030 (USD Million)
  • Table 37 China biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 38 Japan biochip market, by type, 2018 - 2030 (USD Million)
  • Table 39 Japan biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 40 India biochip market, by type, 2018 - 2030 (USD Million)
  • Table 41 India biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea biochip market, by type, 2018 - 2030 (USD Million)
  • Table 43 South Korea biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Australia biochip market, by type, 2018 - 2030 (USD Million)
  • Table 45 Australia biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Thailand biochip market, by type, 2018 - 2030 (USD Million)
  • Table 47 Thailand biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 48 Latin America biochip market, by country, 2018 - 2030 (USD Million)
  • Table 49 Latin America biochip market, by type, 2018 - 2030 (USD Million)
  • Table 50 Latin America biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Brazil biochip market, by type, 2018 - 2030 (USD Million)
  • Table 52 Brazil biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Argentina biochip market, by type, 2018 - 2030 (USD Million)
  • Table 54 Argentina biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa biochip market, by country, 2018 - 2030 (USD Million)
  • Table 56 Middle East & Africa biochip market, by type, 2018 - 2030 (USD Million)
  • Table 57 Middle East & Africa biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 58 South Africa biochip market, by type, 2018 - 2030 (USD Million)
  • Table 59 South Africa biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 60 Saudi Arabia biochip market, by type, 2018 - 2030 (USD Million)
  • Table 61 Saudi Arabia biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 62 UAE biochip market, by type, 2018 - 2030 (USD Million)
  • Table 63 UAE biochip market, by end use, 2018 - 2030 (USD Million)
  • Table 64 Kuwait biochip market, by type, 2018 - 2030 (USD Million)
  • Table 65 Kuwait biochip market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Market formulation & validation
  • Fig. 6 Biochip market: market outlook
  • Fig. 7 Biochip competitive insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Biochip market driver impact
  • Fig. 10 Biochip market restraint impact
  • Fig. 11 Biochip market: Type movement analysis
  • Fig. 12 Biochip market: Type outlook and key takeaways
  • Fig. 13 DNA chips market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Cancer diagnostics & treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Gene expression market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 16 SNP genotyping market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 17 Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Agricultural biotechnology market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 20 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 21 Protein chips market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 22 Proteomics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 23 Expression profiling market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 24 Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 HTS market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Drug discovery market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 28 Lab-on-chip market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 29 Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 IVD & POC market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Proteomics market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 32 Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 34 Biochip market: End use movement analysis
  • Fig. 35 Biochip market: End use outlook and key takeaways
  • Fig. 36 Biotechnology & pharmaceutical companies market estimates and forecasts,2018 - 2030 (USD Million)
  • Fig. 37 Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Hospitals & diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 40 North America biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Canada biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Mexico biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Europe biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 UK biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Germany biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 France biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Italy biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Spain biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Denmark biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Sweden biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Norway biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 China biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Japan biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 India biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Thailand biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 South Korea biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Australia biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Latin America biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Brazil biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Argentina biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Middle East and Africa biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 South Africa biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Saudi Arabia biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 UAE biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 67 Kuwait biochip market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Market share of key market players - Biochip market
目次
Product Code: GVR-1-68038-077-4

Biochip Market Growth & Trends:

The global biochip market size is estimated to reach USD 26.30 billion by 2030, expanding at a CAGR of 11.41% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising requirement for drug discovery and development coupled with the adoption of personalized medicine is likely to favor the industry's growth. Furthermore, the rise in the implementation of next-generation sequencing by biotechnology companies around the globe is pushing product demand. For instance, in December 2021, Abbott received CE Mark for the i-STAT TBI Plasma test, a portable analyzer for Traumatic Brain Injury (TBI) blood. Hence, the company is permitted to expand its footprint in the European Union. The innovation in sequencing techniques has allowed researchers to decode DNA molecules up to the level of the complete human genome.

Ion Torrent chip by Thermo Fisher Scientific is one of the technologies based on sequencing by the technique of synthesis. The chip is an advancement in the Next-Generation Sequencing (NGS) technology that makes massively parallel sequencing cost-effective for every lab. Hence, the development of biochips to enhance the NGS application is anticipated to support the growth of the industry. Similarly, increasing government-based initiatives to promote the domestic production of biochips is likely to support the growth in the coming years. This strategic initiative is to match the local demand for the product with the supply. For instance, in July 2022, SiPhox, Inc. received a grant worth USD 681,631 from the Baker-Polito Administration.

The financial support is to accelerate the development of a manufacturing facility for the mass production of pluggable photonic biochips. It is estimated to accelerate the output to around 5,000 biochips per month from around 100 per month to match the rising demand from biotech segments including drug discovery, vaccine development, and distributed diagnostics. Such investments are likely to supplement the industry growth in the coming years. The COVID-19 pandemic is estimated to have a positive impact on industry growth during the forecasted period. Various companies collaborated to develop innovative solutions to deal with the pandemic. For instance, in March 2020, SkyWater Technology announced the collaboration with MGI, to supply essential components for COVID-19 sequencing, including microfluidic MEMS devices.

The growing requirement for personalized medicine is likely to become a key application area for the industry in the coming years. Since biochip is emerging as an important component in molecular diagnostics, their use in point-of-care diagnostics is anticipated to smooth the development of personalized medicines. In addition, gene expression profiling through microarrays is expected to enhance the progress of personalized treatment for cancer based on molecular classification. However, the cost involved in the manufacturing of biochips is considerably high, resulting in high pricing for end-users. For instance, Josep Carreras Leukaemia Research Institute (IJC) provides microarray to researchers. The cost of GeneChip Human Gene 2.0 ST for whole-transcript expression analysis & profiling ranges from USD 456 to 593 for fresh samples.

Biochip Market Report Highlights:

  • The DNA chips type segment accounted for the largest revenue share in 2024 due to the high demand for rapid and accurate detection of cancer
  • The drug discovery application segment for lab-on-chip is anticipated to grow at a faster rate during the forecast period as the biochip helps lower the overall cost of drug discovery & development
  • The biotechnology and pharmaceutical companies end-user segment captured a significant revenue share in 2024 due to the need for personalized medicines along with the increasing drug discovery & development
  • North America held the largest revenue share in 2024 owing to high R&D investment coupled with the accessibility of capital through venture capitalists for startups and the application development of biochips in the region
  • Asia Pacific is projected to register the fastest CAGR from 2025 to 2030 owing to various initiatives by local governments to promote domestic product manufacturing

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Type Segment
    • 1.1.2. End Use Segment
  • 1.2. Regional Scope
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Primary Research
  • 1.6. Information or Data Analysis:
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Validation
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. List of Abbreviations
  • 1.11. Objective

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increase in adoption of next-generation sequencing
      • 3.2.1.2. Growing R&D in proteomics and genomics
      • 3.2.1.3. Presence of an extensive drug-development pipeline
      • 3.2.1.4. Increasing adoption of personalized medicine
      • 3.2.1.5. Rapid technological advances in biochip technology
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High cost of manufacturing
  • 3.3. Industry Analysis Tools
    • 3.3.1. Porter's Five Forces Analysis
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. Type Group Business Analysis

  • 4.1. Type Segment Dashboard
  • 4.2. Biochip Market Type Movement Analysis
  • 4.3. Biochip Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. DNA Chips
    • 4.4.1. DNA chips market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Cancer Diagnosis and Treatment
      • 4.4.2.1. Cancer diagnosis and treatment market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Gene Expression
      • 4.4.3.1. Gene expression market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. SNP Genotyping
      • 4.4.4.1. SNP genotyping market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Genomics
      • 4.4.5.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.6. Drug Discovery
      • 4.4.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.7. Agricultural Biotechnology
      • 4.4.7.1. Agricultural biotechnology market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.4.8. Others
      • 4.4.8.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.5. Protein Chips
    • 4.5.1. Protein chips market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Proteomics
      • 4.5.2.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Expression Profiling
      • 4.5.3.1. Expression profiling market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.4. Diagnostics
      • 4.5.4.1. Diagnostics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.5. HTS
      • 4.5.5.1. HTS market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.6. Drug Discovery
      • 4.5.6.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.5.7. Others
      • 4.5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.6. Lab-on-chip
    • 4.6.1. Lab-on-chip market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Genomics
      • 4.6.2.1. Genomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. IVD & POC
      • 4.6.3.1. IVD & POC market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.4. Proteomics
      • 4.6.4.1. Proteomics market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.5. Drug Discovery
      • 4.6.5.1. Drug discovery market estimates and forecasts, 2018 - 2030 (USD Million)
    • 4.6.6. Others
      • 4.6.6.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.7. Tissue Arrays
    • 4.7.1. Tissue arrays market estimates and forecasts, 2018 - 2030 (USD Million)
  • 4.8. Cell Arrays
    • 4.8.1. Cell arrays market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 5. End Use Business Analysis

  • 5.1. End Use Segment Dashboard
  • 5.2. Biochip Market End Use Movement Analysis
  • 5.3. Biochip Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.4. Biotechnology & Pharmaceutical Companies
    • 5.4.1. Biotechnology & pharmaceutical companies market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.5. Hospitals & Diagnostic Centers
    • 5.5.1. Hospitals & diagnostic centers market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.6. Academic & Research Institute
    • 5.6.1. Academic & research institute market estimates and forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 - 2030 (USD Million)

Chapter 6. Regional Business Analysis by Type, End Use

  • 6.1. Regional Dashboard
  • 6.2. Market Size & Forecast and Trend Analysis, 2024 & 2030
  • 6.3. North America
    • 6.3.1. North America Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Competitive Scenario
      • 6.3.2.3. Target Disease Prevalence
      • 6.3.2.4. U.S. Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Competitive Scenario
      • 6.3.3.3. Target Disease Prevalence
      • 6.3.3.4. Canada Biochip Market, 2018 - 2030 (USD Million)
    • 6.3.4. Mexico
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Competitive Scenario
      • 6.3.4.3. Target Disease Prevalence
      • 6.3.4.4. Mexico Biochip Market, 2018 - 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. Europe Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.2. UK
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Competitive Scenario
      • 6.4.2.3. Target Disease Prevalence
      • 6.4.2.4. UK Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.3. Germany
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Competitive Scenario
      • 6.4.3.3. Target Disease Prevalence
      • 6.4.3.4. Germany Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.4. France
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Competitive Scenario
      • 6.4.4.3. Target Disease Prevalence
      • 6.4.4.4. France Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.5. Italy
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Competitive Scenario
      • 6.4.5.3. Target Disease Prevalence
      • 6.4.5.4. Italy Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.6. Spain
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Competitive Scenario
      • 6.4.6.3. Target Disease Prevalence
      • 6.4.6.4. Spain Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.7. Denmark
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Competitive Scenario
      • 6.4.7.3. Denmark Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.8. Sweden
      • 6.4.8.1. Key Country Dynamics
      • 6.4.8.2. Competitive Scenario
      • 6.4.8.3. Target Disease Prevalence
      • 6.4.8.4. Sweden Biochip Market, 2018 - 2030 (USD Million)
    • 6.4.9. Norway
      • 6.4.9.1. Key Country Dynamics
      • 6.4.9.2. Competitive Scenario
      • 6.4.9.3. Target Disease Prevalence
      • 6.4.9.4. Norway Biochip Market, 2018 - 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Asia Pacific Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Japan Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.3. China
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. China Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.4. India
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Competitive Scenario
      • 6.5.4.3. Target Disease Prevalence
      • 6.5.4.4. India Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.5. Australia
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Competitive Scenario
      • 6.5.5.3. Target Disease Prevalence
      • 6.5.5.4. Australia Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Target Disease Prevalence
      • 6.5.6.4. Thailand Biochip Market, 2018 - 2030 (USD Million)
    • 6.5.7. South Korea
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Target Disease Prevalence
      • 6.5.7.4. South Korea Biochip Market, 2018 - 2030 (USD Million)
  • 6.6. Latin America
    • 6.6.1. Latin America Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.2. Brazil
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Target Disease Prevalence
      • 6.6.2.4. Brazil Biochip Market, 2018 - 2030 (USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Target Disease Prevalence
      • 6.6.3.4. Argentina Biochip Market, 2018 - 2030 (USD Million)
  • 6.7. MEA
    • 6.7.1. MEA Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Target Disease Prevalence
      • 6.7.2.4. South Africa Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.3. Saudi Arabia
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Target Disease Prevalence
      • 6.7.3.4. Saudi Arabia Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.4. UAE
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Target Disease Prevalence
      • 6.7.4.4. UAE Biochip Market, 2018 - 2030 (USD Million)
    • 6.7.5. Kuwait
      • 6.7.5.1. Key Country Dynamics
      • 6.7.5.2. Competitive Scenario
      • 6.7.5.3. Target Disease Prevalence
      • 6.7.5.4. Kuwait Biochip Market, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Company Categorization
  • 7.2. Strategy Mapping
  • 7.3. Company Market Position Analysis, 2024
  • 7.4. Company Profiles/Listing
    • 7.4.1. Agilent Technologies
      • 7.4.1.1. Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Strategic Initiatives
    • 7.4.2. PerkinElmer, Inc.
      • 7.4.2.1. Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Strategic Initiatives
    • 7.4.3. Illumina, Inc.
      • 7.4.3.1. Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Strategic Initiatives
    • 7.4.4. Bio-Rad Laboratories, Inc.
      • 7.4.4.1. Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Strategic Initiatives
    • 7.4.5. Standard BioTools Inc.
      • 7.4.5.1. Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Strategic Initiatives
    • 7.4.6. GE HealthCare
      • 7.4.6.1. Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Strategic Initiatives
    • 7.4.7. IBIOCHIPS
      • 7.4.7.1. Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Strategic Initiatives
    • 7.4.8. LI-COR, Inc.
      • 7.4.8.1. Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Strategic Initiatives
    • 7.4.9. Cellix Ltd
      • 7.4.9.1. Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Strategic Initiatives
    • 7.4.10. Randox Laboratories Ltd.
      • 7.4.10.1. Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Strategic Initiatives